Booking platforms Intranet

Booking platforms Intranet

The institute
- Pages
- Directory
- About C3M…
The research
- Pages
- The research teams
- The publications
- The patents
the platforms
- Pages
- Cytometry
- Histology
- Genomics
- Metabolism
- Shared services

Events
Jobs

Home pagePublications PubMed

Tocilizumab for Corticosteroid-Refractory Immune Checkpoint Inhibitor-Induced Generalized Morphea.

JAMA dermatology Nov 2022

Description

Author

Blaise M, Cardot-Leccia N, Seitz-Polski B, Picard-Gauci A, Bertold C, Passeron T, Montaudié H

Read the article

Supporting research

Follow us on:

Our supervision :

Our partners :

C3M – Inserm U1065 © 2021 - All rights reserved

Research 0 result(s)